Clinical Trials in Kalispell, United States
Locations / Kalispell, United States
Delta Trials records 96 clinical trials conducted in Kalispell, United States, making it a notable site of clinical research activity. These trials across 641 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Kalispell has changed over time.
96
Total Trials
641
Conditions
0
Terminated since 2020
Browse by condition (641 total)
- Metastatic malignant solid neoplasm 6 trialsAll Metastatic malignant solid neoplasm trials
- Stage iiib lung cancer ajcc v8 6 trialsAll Stage iiib lung cancer ajcc v8 trials
- Acute myeloid leukemia 5 trialsAll Acute myeloid leukemia trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- Stage ii lung cancer ajcc v8 4 trialsAll Stage ii lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- Malignant solid neoplasm 4 trialsAll Malignant solid neoplasm trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Advanced malignant solid neoplasm 3 trialsAll Advanced malignant solid neoplasm trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- All Clinical stage iv cutaneous melanoma ajcc v8 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- All Endometrial mixed cell adenocarcinoma trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- Stage iii lung cancer ajcc v8 3 trialsAll Stage iii lung cancer ajcc v8 trials
- Myelodysplastic syndrome 3 trialsAll Myelodysplastic syndrome trials
- Ovarian seromucinous carcinoma 3 trialsAll Ovarian seromucinous carcinoma trials
- Lung non-small cell carcinoma 3 trialsAll Lung non-small cell carcinoma trials